Trexquant Investment’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,503
| Closed | -$132K | – | 1974 |
|
|
2022
Q1 | $132K | Sell |
19,503
-29,881
| -61% | -$202K | 0.01% | 1260 |
|
|
2021
Q4 | $412K | Buy |
+49,384
| New | +$412K | 0.03% | 748 |
|
|
2021
Q3 | – | Sell |
-33,322
| Closed | -$227K | – | 1602 |
|
|
2021
Q2 | $227K | Buy |
+33,322
| New | +$227K | 0.02% | 849 |
|
|
2021
Q1 | – | Sell |
-24,204
| Closed | -$169K | – | 1573 |
|
|
2020
Q4 | $169K | Buy |
+24,204
| New | +$169K | 0.02% | 924 |
|
|
2020
Q1 | – | Sell |
-68,528
| Closed | -$598K | – | 1508 |
|
|
2019
Q4 | $598K | Buy |
+68,528
| New | +$598K | 0.04% | 505 |
|
|
2018
Q4 | – | Sell |
-33,197
| Closed | -$216K | – | 1385 |
|
|
2018
Q3 | $216K | Buy |
+33,197
| New | +$216K | 0.02% | 801 |
|